More than 130,000 people in the UK live with multiple sclerosis (MS). Magnetic resonance imaging (MRI) is central to their diagnosis and care, yet almost all NHS centres face long delays because there are too few specialist neuroradiologists to report scans quickly...
Scientists from The University of Manchester have identified a brief window after brain tumour surgery during which a treatment for glioblastoma, an incurable brain cancer, can cross the brain’s protective barrier and reach the cancer cells most likely to trigger...
A University of Manchester student who underwent epilepsy surgery at Salford Royal is helping shape the next generation of healthcare professionals by sharing her experience with trainee clinical psychologists.Leilah Applegarth, who is studying for a Postgraduate...
When Daniel Ko arrived at The University of Manchester as an undergraduate neuroscience student in 2004, he could not have known that his degree would take him around the world and eventually bring him back to Manchester with an innovative neurotechnology company and...
The Manchester Rare Conditions Centre which aims to improve the lives of people living with rare conditions and the Geoffrey Jefferson Brain Research Centre recently held a joint workshop to facilitate closer collaboration between our research communities. Following...
NCA is to be part of a new NIHR Translational Research Collaboration (TRC) in Parkinson’s disease (PD), bringing together national expertise and infrastructure.
We are delighted to share our annual report for 2025/26. The report highlights our progress over the past year, including key research achievements, strategic developments, and ongoing collaborations across our clinical and academic community. Download the report 2026...
Researchers from our brain tumour theme are set to begin a new MRC-funded study into inflammation that drives tumour growth in vestibular schwannoma…
Eight patients have been treated at Northern Care Alliance in the world’s first-in-human study of graphene-brain interfaces to map and monitor brain activity and so improve precision during brain tumour surgery.
A clotbusting drug commonly used to treat ischemic stroke interacts negatively with a promising anti-inflammatory treatment (anakinra), underscoring the need…
Geoffrey Jefferson Brain Research Centre
Clinical Sciences Building
Northern Care Alliance
NHS Foundation Trust
Salford
M6 8FJ
Email: GJBRC@manchester.ac.uk
Recent Comments